The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
Abstract
PITUITARY tumors are common neoplasms that exhibit a wide range of biological behavior, in terms of hormonal and proliferative activities. Their hormonal activity is usually reflective of their cytodifferentiation. The adenohypophysis is a complex gland composed of several cell types that are responsible for the production of many hormones. It was once believed that one cell could make only one hormone (1); the concept of plurihormonality in pituitary adenomas was once controversial and poorly understood. However, advances in our recognition of the factors that regulate cell differentiation in the adenohypophysis have led to a new classification of adenohypophysial cell types (2) and a more sophisticated understanding of the mechanisms that determine the patterns of hormone production in pituitary adenomas. For many years there has been controversy regarding the basis of pituitary tumorigenesis. Two prevailing theories have pitted hormonal stimulation against an intrinsic pituitary defect. Several animal models have provided support for the role of hormonal stimulation in the development of these neoplasms, and there is evidence for adenohypophysial production of hypothalamic hypophysiotropic hormones that may be responsible for excess stimulation. Other growth factors have also been shown to cause pituitary tumors. In contrast, the clonal nature of pituitary adenomas and the lack of associated hyperplasia in most patients with pituitary adenomas argue for a molecular defect as the etiology of these lesions. An integrated approach reconciles the two proposed theories of tumorigenesis by applying the multistep theory of carcinogenesis. It is likely that the majority of pituitary adenomas develop from transformed cells that are, nevertheless, dependent on hormonal and/or growth factor stimulation for tumor progression, which will be discussed below.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11162 · Cited by 1,898
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Luo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Structural Characterization and Biological Functions of Fibroblast Growth Factor
GOSPODAROWICZ, D., FERRARA, N., SCHWEIGERER, L., & NEUFELD, G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-95 · Cited by 1,273
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Li, S., Crenshaw, E. B., Rawson, E. J., Simmons, D. M., Swanson, L. W., & Rosenfeld, M. G. (1990) · Nature · doi:10.1038/347528a0 · Cited by 1,196
Human Estrogen Receptor β-Gene Structure, Chromosomal Localization, and Expression Pattern1
Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjöld, M., & Gustafsson, J.-A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4470 · Cited by 1,074
Two G Protein Oncogenes in Human Endocrine Tumors
Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q.-Y., Clark, O. H., Kawasaki, E., Bourne, H. R., et al. (1990) · Science · doi:10.1126/science.2116665 · Cited by 1,037
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype
Ingraham, H. A., Chen, R., Mangalam, H. J., Elsholtz, H. P., Flynn, S. E., Lin, C. R., Simmons, D. M., Swanson, L., & Rosenfeld, M. G. (1988) · Cell · doi:10.1016/0092-8674(88)90038-4 · Cited by 979
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
YING, S.-Y. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-267 · Cited by 820
Sornson, M. W., Wu, W., Dasen, J. S., Flynn, S. E., Norman, D. J., O'Connell, S. M., Gukovsky, I., Carrière, C., Ryan, A. K., Miller, A. P., et al. (1996) · Nature · doi:10.1038/384327a0 · Cited by 788
The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein
Bodner, M., Castriilo, J.-L., Theill, L. E., Deerinck, T., Ellisman, M., & Karin, M. (1988) · Cell · doi:10.1016/0092-8674(88)90037-2 · Cited by 757
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system
Marchionni, M. A., Goodearl, A. D. J., Su Chen, M., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., et al. (1993) · Nature · doi:10.1038/362312a0 · Cited by 738
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
Molecular Biology of the Pituitary Gonadotropins
GHARIB, S. D., WIERMAN, M. E., SHUPNIK, M. A., & CHIN, W. W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-1-177 · Cited by 699
Lala, D. S. (1992) · Molecular Endocrinology · doi:10.1210/me.6.8.1249 · Cited by 678 · cited 1×
“The nuclear receptor SF-1 is a member of the steroid receptor superfamily that was identified independently in mouse (140) and bovine steroidogenic tissues (141) and was shown to be a transcription factor that regulates the expression of the steroidogenic enzymes cytochrome P450 CYP11A and CYP11B.”
BackgroundSimmons, D. M., Voss, J. W., Ingraham, H. A., Holloway, J. M., Broide, R. S., Rosenfeld, M. G., & Swanson, L. W. (1990) · Genes & Development · doi:10.1101/gad.4.5.695 · Cited by 634
Ikeda, Y. (1994) · Molecular Endocrinology · doi:10.1210/me.8.5.654 · Cited by 628
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis.
Ingraham, H. A., Lala, D. S., Ikeda, Y., Luo, X., Shen, W. H., Nachtigal, M. W., Abbud, R., Nilson, J. H., & Parker, K. L. (1994) · Genes & Development · doi:10.1101/gad.8.19.2302 · Cited by 602
Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)
Pei, L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.433 · Cited by 576
Mutations in PROP1 cause familial combined pituitary hormone deficiency
Wu, W., Cogan, J. D., Pfäffle, R. W., Dasen, J. S., Frisch, H., O'Connell, S. M., Flynn, S. E., Brown, M. R., Mullis, P. E., Parks, J. S., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-147 · Cited by 568
Clonal Origin of Pituitary Adenomas*
HERMAN, V., FAGIN, J., GONSKY, R., KOVACS, K., & MELMED, S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1427 · Cited by 560
Gospodarowicz, D., Abraham, J. A., & Schilling, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7311 · Cited by 559
Shen, W.-H., Moore, C. C. D., Ikeda, Y., Parker, K. L., & Ingraham, H. A. (1994) · Cell · doi:10.1016/0092-8674(94)90050-7 · Cited by 559
Peters, K. G., Werner, S., Chen, G., & Williams, L. T. (1992) · Development · doi:10.1242/dev.114.1.233 · Cited by 543
A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s.
Morohashi, K., Honda, S., Inomata, Y., Handa, H., & Omura, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37129-7 · Cited by 542
The ins and outs of fibroblast growth factors
Mason, I. J. (1994) · Cell · doi:10.1016/0092-8674(94)90520-7 · Cited by 524
Nelson, C., Albert, V. R., Elsholtz, H. P., Lu, L. I.-W., & Rosenfeld, M. G. (1988) · Science · doi:10.1126/science.2831625 · Cited by 513
Microadenomas of the Pituitary and Abnormal Sellar Tomograms in an Unselected Autopsy Series
Burrow, G. N., Wortzman, G., Rewcastle, N. B., Holgate, R. C., & Kovacs, K. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101153040306 · Cited by 486
Molecular basis of the little mouse phenotype and Implications for cell type-specific growth
Lin, S.-C., Lin, C. R., Gukovsky, I., Lusis, A. J., Sawchenko, P. E., & Rosenfeld, M. G. (1993) · Nature · doi:10.1038/364208a0 · Cited by 474
Thapar, K., Kovacs, K., Scheithauer, B. W., Stefaneanu, L., Horvath, E., Peter J., P., Murray, D., & Laws, E. R. (1996) · Neurosurgery · doi:10.1097/00006123-199601000-00024 · Cited by 462
Mutation of the POU-Specific Domain of Pit-1 and Hypopituitarism Without Pituitary Hypoplasia
Pfäffle, R. W., DiMattia, G. E., Parks, J. S., Brown, M. R., Wit, J. M., Jansen, M., Van der Nat, H., Van den Brande, J. L., Rosenfeld, M. G., & Ingraham, H. A. (1992) · Science · doi:10.1126/science.257.5073.1118 · Cited by 454
A Mutation in the POU-Homeodomain of Pit-1 Responsible for Combined Pituitary Hormone Deficiency
Radovick, S., Nations, M., Du, Y., Berg, L. A., Weintraub, B. D., & Wondisford, F. E. (1992) · Science · doi:10.1126/science.257.5073.1115 · Cited by 449
POU-domain transcription factors: pou-er-ful developmental regulators.
Rosenfeld, M. G. (1991) · Genes & Development · doi:10.1101/gad.5.6.897 · Cited by 447
Complexity of FGF receptors: genetic basis for structural diversity and functional specificity
Givol, D., & Yayon, A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1464370 · Cited by 435
Ikeda, Y. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.478 · Cited by 429
Kelly, M. A., Rubinstein, M., Asa, S. L., Zhang, G., Saez, C., Bunzow, J. R., Allen, R. G., Hnasko, R., Ben-Jonathan, N., Grandy, D. K., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80351-7 · Cited by 426
Self-citationLamonerie, T., Tremblay, J. J., Lanctôt, C., Therrien, M., Gauthier, Y., & Drouin, J. (1996) · Genes & Development · doi:10.1101/gad.10.10.1284 · Cited by 421
Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily.
Honda, S., Morohashi, K., Nomura, M., Takeya, H., Kitajima, M., & Omura, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53202-6 · Cited by 412
Stabel, S., & Parker, P. J. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90042-k · Cited by 408
Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S., & McKeehan, W. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4513 · Cited by 403
Ikeda, Y. (1993) · Molecular Endocrinology · doi:10.1210/me.7.7.852 · Cited by 400
Godfrey, P., Rahal, J. O., Beamer, W. G., Copeland, N. G., Jenkins, N. A., & Mayo, K. E. (1993) · Nature Genetics · doi:10.1038/ng0793-227 · Cited by 397
Thorner, M. O., Perryman, R. L., Cronin, M. J., Rogol, A. D., Draznin, M., Johanson, A., Vale, W., Horvath, E., & Kovacs, K. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110708 · Cited by 393
Delegeane, A. M., Ferland, L. H., & Mellon, P. L. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.11.3994 · Cited by 393
Multistep Control of Pituitary Organogenesis
Sheng, H. Z., Moriyama, K., Yamashita, T., Li, H., Potter, S. S., Mahon, K. A., & Westphal, H. (1997) · Science · doi:10.1126/science.278.5344.1809 · Cited by 384
Metabolism and Effects of Epidermal Growth Factor and Related Growth Factors in Mammals*
FISHER, D. A., & LAKSHMANAN, J. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-3-418 · Cited by 374
Hurley, D. M., Accili, D., Stratakis, C. A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S. I., & Chrousos, G. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115046 · Cited by 370 · cited 1×
“Specific point mutations resulting in diminished ligand binding in the glucocorticoid hormone-binding domain are now known in cases of familial glucocorticoid resistance (235), and a novel germ line mutation of this sort has been reported to result in pituitary Cushing’s disease (236).”
BackgroundClinically nonfunctioning pituitary tumors are monoclonal in origin.
Alexander, J. M., Biller, B. M., Bikkal, H., Zervas, N. T., Arnold, A., & Klibanski, A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114705 · Cited by 366
Mayo, K. E. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1734 · Cited by 365
Transsphenoidal microsurgical removal of 250 pituitary adenomas
Wilson, C. B., & Dempsey, L. C. (1978) · Journal of Neurosurgery · doi:10.3171/jns.1978.48.1.0013 · Cited by 346
Mangalam, H. J., Albert, V. R., Ingraham, H. A., Kapiloff, M., Wilson, L., Nelson, C., Elsholtz, H., & Rosenfeld, M. G. (1989) · Genes & Development · doi:10.1101/gad.3.7.946 · Cited by 345
Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene
Tatsumi, K.-I., Miyai, K., Notomi, T., Kaibe, K., Amino, N., Mizuno, Y., & Kohno, H. (1992) · Nature Genetics · doi:10.1038/ng0492-56 · Cited by 337
Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro.
Billestrup, N., Swanson, L. W., & Vale, W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6854 · Cited by 325
Lin, C., Lin, S.-C., Chang, C.-P., & Rosenfeld, M. G. (1992) · Nature · doi:10.1038/360765a0 · Cited by 325
Subclinical Adenoma of the Pituitary Gland.
Costello, R. T. (1936) · PubMed Central · Cited by 324
Modern imaging of the pituitary.
Elster, A. D. (1993) · Radiology · doi:10.1148/radiology.187.1.8451394 · Cited by 322
Dwarf mice produced by genetic ablation of growth hormone-expressing cells.
Behringer, R. R., Mathews, L. S., Palmiter, R. D., & Brinster, R. L. (1988) · Genes & Development · doi:10.1101/gad.2.4.453 · Cited by 317
Tremblay, J. J. (1998) · Molecular Endocrinology · doi:10.1210/me.12.3.428 · Cited by 316
Mechanisms of signal transduction at the dopamine D2 receptor
Vallar, L., & Meldolesi, J. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90082-5 · Cited by 312
Beerli, R. R., & Hynes, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6071 · Cited by 308
Macleod, K., Leprince, D., & Stehelin, D. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90404-w · Cited by 304
Transgenic mice with inducible dwarfism
Borrelli, E., Heyman, R. A., Arias, C., Sawchenko, P. E., & Evans, R. M. (1989) · Nature · doi:10.1038/339538a0 · Cited by 304
Age‐related and gender‐related occurrence of pituitary adenomas
Mindermann, T., & Wilson, C. B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02557.x · Cited by 304
Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant
Struthers, R. S., Vale, W. W., Arias, C., Sawchenko, P. E., & Montminy, M. R. (1991) · Nature · doi:10.1038/350622a0 · Cited by 301
Lloyd, R. V., Scheithauer, B. W., Horvath, E., & Kovacs, K. (2009) · Surgical Pathology of Endocrine and Neuroendocrine Tumors · doi:10.1007/978-1-60327-396-1_4 · Cited by 298
Byström, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., & Nordenskjöld, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1968 · Cited by 295
Bodner, M., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90222-4 · Cited by 293
Bach, I., Rhodes, S. J., Pearse, R. V., Heinzel, T., Gloss, B., Scully, K. M., Sawchenko, P. E., & Rosenfeld, M. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2720 · Cited by 291
Hermesz, E., Mackem, S., & Mahon, K. A. (1996) · Development · doi:10.1242/dev.122.1.41 · Cited by 290
The Pituitary Gland in Pregnancy: A Clinicopathologic and Immunohistochemical Study of 69 Cases
SCHEITHAUER, B. W., SANO, T., KOVACS, K. T., YOUNG, W. F., RYAN, N., & RANDALL, R. V. (1990) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60946-x · Cited by 286
Carey, R. M., Varma, S. K., Drake, C. R., Thorner, M. O., Kovacs, K., Rivier, J., & Vale, W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407053110103 · Cited by 281
SANO, T., ASA, S. L., & KOVACS, K. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-357 · Cited by 268
Self-citationGonadotroph Cell Adenomas of the Pituitary*
Snyder, P. J. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-4-552 · Cited by 268
Hu, N., Gutsmann, A., Herbert, D. C., Bradley, A., Lee, W., & Lee, E. Y. (1994) · PubMed · Cited by 266
Barnhart, K. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.7.878 · Cited by 247
Drolet, D. W., Scully, K. M., Simmons, D. M., Wegner, M., Chu, K. T., Swanson, L. W., & Rosenfeld, M. G. (1991) · Genes & Development · doi:10.1101/gad.5.10.1739 · Cited by 246
Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang, Z., Ezzat, S., Vortmeyer, A. O., Weil, R. J., Oldfield, E. H., Park, W. S., Pack, S., Huang, S. C., Agarwal, S. K., Guru, S. C., et al. (1997) · PubMed · Cited by 246
Self-citationDissection of functional domains of the pituitary-specific transcription factor GHF-1
Theill, L. E., Castrillo, J.-L., Wu, D., & Karin, M. (1989) · Nature · doi:10.1038/342945a0 · Cited by 245
Goldman, R., Ben Levy, R., Peles, E., & Yarden, Y. (1990) · Biochemistry · doi:10.1021/bi00502a002 · Cited by 244
Hsieh, K. P. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1673 · Cited by 241
Werner, S., Weinberg, W., Liao, X., Peters, K. G., Blessing, M., Yuspa, S. H., Weiner, R. L., & Williams, L. T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05924.x · Cited by 238
Maurer, R. A., & Notides, A. C. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.12.4247 · Cited by 234
NeuroD1/β2 Contributes to Cell-Specific Transcription of the Proopiomelanocortin Gene
Poulin, G., Turgeon, B., & Drouin, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6673 · Cited by 231
Gage, P. J., & Camper, S. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.457 · Cited by 230
Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements
Chen, R., Ingraham, H. A., Treacy, M. N., Albert, V. R., Wilson, L., & Rosenfeld, M. G. (1990) · Nature · doi:10.1038/346583a0 · Cited by 225
Somatostatin receptor subtype gene expression in pituitary adenomas
Miller, G. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1386 · Cited by 220
Function of the Homeodomain Protein GHF1 in Pituitary Cell Proliferation
Castrillo, J.-L., Theill, L. E., & Karin, M. (1991) · Science · doi:10.1126/science.1677216 · Cited by 218
Morohashi, K. (1993) · Molecular Endocrinology · doi:10.1210/me.7.9.1196 · Cited by 217
H-ras mutations in human pituitary carcinoma metastases
Pei, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.4.842 · Cited by 216
Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues
McCormick, A., Brady, H., Theill, L. E., & Karin, M. (1990) · Nature · doi:10.1038/345829a0 · Cited by 212
Pei, L., Melmed, S. K., Scheithauer, B. W., Kovács, K., Benedict, W. F., & Prager, D. (1995) · PubMed · Cited by 212
Dollé, P., Castrillo, J.-L., Theill, L. E., Deerinck, T., Ellisman, M., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90095-v · Cited by 209
Molecular genetic studies of sporadic pituitary tumors
Boggild, M., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., McTernan, P. G., Perrett, C. W., Thakker, R. V., & Clayton, R. N. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106627 · Cited by 200
Day, R. N., Koike, S., Sakai, M., Muramatsu, M., & Maurer, R. A. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1964 · Cited by 197
Role of Estrogen Receptor-α in the Anterior Pituitary Gland
Scully, K. M., Gleiberman, A. S., Lindzey, J., Lubahn, D. B., Korach, K. S., & Rosenfeld, M. G. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0019 · Cited by 196
Transcriptional Control of GH Expression and Anterior Pituitary Development*
THEILL, L. E., & KARIN, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-670 · Cited by 194
Pituitary adenomas in childhood and adolescence
Kane, L. A., Leinung, M. C., Scheithauer, B. W., Bergstralh, E. J., Laws, E. R., Groover, R. V., Kovács, K., Horváth, É., & Zimmerman, D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7525627 · Cited by 194
Epidermal growth factor rapidly stimulates prolactin gene transcription
Murdoch, G. H., Potter, E., Nicolaisen, A. K., Evans, R. M., & Rosenfeld, M. G. (1982) · Nature · doi:10.1038/300192a0 · Cited by 193
Estrogen control of prolactin synthesis in vitro.
Lieberman, M. E., Maurer, R. A., & Gorski, J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.12.5946 · Cited by 189
Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene
Burton, F. H., Hasel, K. W., Bloom, F. E., & Sutcliffe, J. G. (1991) · Nature · doi:10.1038/350074a0 · Cited by 187
WIEDEMANN, E., SCHWARTZ, E., & FRANTZ, A. G. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-5-942 · Cited by 187
Lin, S.-C., Li, S., Drolet, D. W., & Rosenfeld, M. G. (1994) · Development · doi:10.1242/dev.120.3.515 · Cited by 184
Karl, M., Lamberts, S. W. J., Koper, J. W., Katz, D. A., Huizenga, N. A. T. M., Kino, T., Haddad, B. R., Hughes, M. R., & Chrousos, G. P. (1996) · PubMed · Cited by 180
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall, W. C., Qian, X., Peterson, N. C., Miller, M. J., Samanta, A., & Greene, M. I. (1994) · PubMed · Cited by 180
FRAWLEY, L. S., BOOCKFOR, F. R., & HOEFFLER, J. P. (1985) · Endocrinology · doi:10.1210/endo-116-2-734 · Cited by 176
Chronic Administration of Corticotropin-Releasing Factor Increases Pituitary Corticotroph Number*
GERTZ, B. J., CONTRERAS, L. N., McCOMB, D. J., KOVACS, K., TYRRELL, J. B., & DALLMAN, M. F. (1987) · Endocrinology · doi:10.1210/endo-120-1-381 · Cited by 174
Qian, X., LeVea, C., Freeman, J. K., Dougall, W. C., & Greene, M. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1500 · Cited by 173
Crenshaw, E. B., Kalla, K., Simmons, D. M., Swanson, L. W., & Rosenfeld, M. G. (1989) · Genes & Development · doi:10.1101/gad.3.7.959 · Cited by 169
Physiopathology of Cushing's Disease
KRIEGER, D. T. (1983) · Endocrine Reviews · doi:10.1210/edrv-4-1-22 · Cited by 169
Waterman, M. L., Adlerf, S., Nelson, C., Greene, G. L., Evans, R. M., & Rosenfeld, M. G. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-1-14 · Cited by 168
Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues
Morohashi, K. (1994) · Molecular Endocrinology · doi:10.1210/me.8.5.643 · Cited by 168
Molecular screening of pituitary adenomas for gene mutations and rearrangements
Herman, V. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.50 · Cited by 167
Gage, P. J. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1570 · Cited by 166
EPIDEMIOLOGY OF PITUITARY ADENOMAS
GOLD, E. B. (1981) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036232 · Cited by 166
Transforming growth factor-alpha is a potential mediator of estrogen action in the mouse uterus
Nelson, K. G. (1992) · Endocrinology · doi:10.1210/en.131.4.1657 · Cited by 161
Growth rate of human pituitary adenomas
Landolt, A. M., SHIBATA, T., & Kleihues, P. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.67.6.0803 · Cited by 157
Asa, S. L., Kovács, K., TINDALL, G. T., Barrow, D. L., Horváth, É., & VECSEI, P. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-789 · Cited by 152
Self-citationp53 gene mutations in pituitary adenomas: rare events
Levy, A., Hall, L., Yeudall, W. A., & Lightman, S. L. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02797.x · Cited by 150
Therrien, M., & Drouin, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2342 · Cited by 150
Verrijzer, C. P., Kal, A. J., & van der Vliet, P. C. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08314.x · Cited by 149
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.
Thakker, R. V., Pook, M. A., Wooding, C., Boscaro, M., Scanarini, M., & Clayton, R. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116524 · Cited by 148
Thyrotropin-Secreting Pituitary Adenomas: Clinical and Biochemical Heterogeneity
Gesundheit, N., Petrick, P. A., Nissim, M., Dahlberg, P. A., Doppman, J. L., Emerson, C. H., Braverman, L. E., Oldfield, E. H., & Bruce, D. W. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-10-827 · Cited by 142
Null cell adenoma of the human pituitary
Kovács, K., Horváth, É., Ryan, N., & EZRIN, C. (1980) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00430697 · Cited by 141
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
Flier, J. S., Underhill, L. H., Klibanski, A., & Zervas, N. T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241207 · Cited by 141
Senogles, S. E., Benovic, J., Amlaiky, N., Unson, C. G., Milligan, G., Vinitsky, R., Spiegel, A. M., & Caron, M. G. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61275-x · Cited by 137
Asa, S. L., Bamberger, A., Cao, B., Wong, M., Parker, K. L., & Ezzat, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964846 · Cited by 136
Self-citationMcAndrew, J., Paterson, A. J., Asa, S. L., McCarthy, K. J., & Kudlow, J. E. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664668 · Cited by 134
Self-citationAsa, S. L., Puy, L. A., Lew, A. M., Sundmark, V. C., & Elsholtz, H. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077321 · Cited by 133
Self-citationFofanova, Q., Takamura, N., Kinoshita, E., Parks, J. S., Brown, M. R., Peterkova, V. A., Evgrafov, O. V., Гончаров, Н. П., Булатов, А. А., Dedov, I. I., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.5094 · Cited by 132
Functional endocrine pathology
Kovács, K. A., & Asa, S. L. (1991) · Cited by 131
Self-citationKovács, K., Ryan, N., Horváth, É., Singer, W., & EZRIN, C. (1980) · Journal of Gerontology · doi:10.1093/geronj/35.1.16 · Cited by 130
Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C
Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B., & BRESSION, D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077302 · Cited by 129
Divergent Effects of Estradiol on Gonadotropin Gene Transcription in Pituitary Fragments
Shupnik, M. A., GHARIB, S. D., & Chin, W. W. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-3-474 · Cited by 127
Ingraham, H. A., Albert, V. R., Chen, R., Crenshaw, E. B., He, H. P. E. X., Kapiloff, M. S., Mangalam, H., Swanson, L. W., Treacy, M. N., & Rosenfeld, M. G. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.004013 · Cited by 127
Friend, K. E., Chiou, Y.-K., Lopes, M. B. S., Laws, E. R., Hughes, K. M., & Shupnik, M. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1497 · Cited by 126
Multiple adenomas of the human pituitary
Kontogeorgos, G., Kovács, K., Horváth, É., & Scheithauer, B. W. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.2.0243 · Cited by 126
Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene
Karl, M., von Wichert, G., Kempter, E., Katz, D. A., Reincke, M., Mönig, H., Ali, I. U., Stratakis, C. A., Oldfield, E. H., Chrousos, G. P., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550738 · Cited by 126
Kovács, K., Ştefăneanu, L., Ezzat, S., & Smyth, H. S. (1994) · PubMed · Cited by 125
Self-citationHorváth, É., Lloyd, R. V., & Kovács, K. (1990) · PubMed · Cited by 125
Bradford, A. P., Conrad, K. E., Wasylyk, C., Wasylyk, B., & Gutierrez‐Hartmann, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2849 · Cited by 121
Purification of Growth Hormone-Specific Transcription Factor GHF-1 Containing Homeobox
Castrillo, J.-L., Bodner, M., & Karin, M. (1989) · Science · doi:10.1126/science.2563596 · Cited by 120
Theill, L. E., Hattori, K., Lazzaro, D., Castrillo, J. L., & Karin, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05285.x · Cited by 118
Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis.
Asa, S. L., Penz, G., Kovács, K., & EZRIN, C. (1982) · PubMed · Cited by 114
Self-citationMonoclonality of corticotroph macroadenomas in Cushing's disease
Gicquel, C., Bouc, Y. L., LUTON, J. P., Girard, F., & BERTAGNA, X. Y. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1322426 · Cited by 114
Keefer, D. A., Stumpf, W. E., & Petrusz, P. (1976) · Cell and Tissue Research · doi:10.1007/bf00215122 · Cited by 111
Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Saito, S., & 板倉, 光. (1992) · PubMed · Cited by 111
Schulte, H. M., Oldfield, E. H., Allolio, B., Katz, D. A., Berkman, R. A., & ALI, I. U. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1302 · Cited by 108
Simard, J., Hubert, J., Hosseinzadeh, T., & Labrie, F. (1986) · Endocrinology · doi:10.1210/endo-119-5-2004 · Cited by 108
Alternative splicing generates at least five different isoforms of the human basic-FGF receptor.
Eisemann, A., Ahn, J.-K., Graziani, G., et al. (1991) · PubMed · Cited by 104
Pituitary gland in hypothyroidism. Histologic and immunocytologic study.
Scheithauer, B. W., Kovács, K., Randall, R. V., & Ryan, N. (1985) · PubMed · Cited by 104
Frequent loss of the P16INK4a gene product in human pituitary tumors.
Woloschak, M., Yu, A., Xiao, J., & Post, K. D. (1996) · PubMed · Cited by 102
Ştefăneanu, L., Kovács, K., Lloyd, R. V., Scheithauer, B. W., Young, W. F., Sano, T., & Jin, L. G. (1992) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899695 · Cited by 102
White, B. A., & Bancroft, F. C. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32668-1 · Cited by 101
Steinfelder, H. J., Radovick, S., & Wondisford, F. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5942 · Cited by 99
Asa, S. L., Kovács, K., László, F. A., Domokos, I., & EZRIN, C. (2008) · Neuroendocrinology · doi:10.1159/000124545 · Cited by 99
Self-citationPrevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules
Ezzat, S., Zheng, L., KOLENDA, J., SAFARIAN, A., Freeman, J. L., & Asa, S. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.409 · Cited by 98
Self-citationNormal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors
Friedman, E., Adams, E. F., Höög, A., Gejman, P. V., Carson, E., Larsson, C., Marco, L. A. D., Werner, S., Fahlbusch, R., & Nordenskjöld, M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.568 · Cited by 96
Dopamine, the dopamine D2 receptor and pituitary tumours
Wood, D., Johnston, J., & Johnston, D. G. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00928.x · Cited by 96
Functional isoforms of Pit-1 generated by alternative messenger RNA splicing.
Konzak, K. E., & Moore, D. D. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.2.1569967 · Cited by 96
Identification of soluble forms of the fibroblast growth factor receptor in blood.
Hanneken, A. M., Ying, W., LING, N. C., & Baird, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9170 · Cited by 94
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
Missale, C., Boroni, F., Losa, M., Giovanelli, M. A., Zanellato, A., Toso, R. D., Balsari, A., & Spano, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7961 · Cited by 93
Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus
Zhu, J., Leon, S. P., Beggs, A. H., Busque, L., Gilliland, D. G., & Black, P. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.4.922 · Cited by 88
An alternatively spliced Pit-1 isoform altered in its ability to trans-activate
Morris, A. E., Kloss, B., McChesney, R. E., Bancroft, C., & Chasin, L. A. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1355 · Cited by 87
Childs, G. V., ROUGEAU, D., & Unabia, G. C. (1995) · Endocrinology · doi:10.1210/endo.136.4.7895669 · Cited by 87
Hashimoto, K., Koga, M., Motomura, T., Kasayama, S., Kouhara, H., Ohnishi, T., Arita, N., Hayakawa, T., Sato, B., & Kishimoto, T. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.2933 · Cited by 86
Pituitary hyperplasia induced by ectopic expression of nerve growth factor.
Borrelli, E., Sawchenko, P. E., & Evans, R. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2764 · Cited by 85
Surgical pathology of the pituitary: the adenomas. Part I.
Scheithauer, B. W. (1984) · PubMed · Cited by 84
A thyrotrope-specific variant of Pit-1 transactivates the thyrotropin beta promoter.
Haugen, B. R., Wood, W. M., Gordon, D. F., & Ridgway, E. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36858-9 · Cited by 82
Shupnik, M. A., Weinmann, C. M., Notides, A. C., & Chin, W. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31226-7 · Cited by 81
Bw, S., Kovács, K. J., & Randall, R. V. (1983) · PubMed · Cited by 78
Shimon, I., Huttner, A. J., Said, J., Spirina, O., & Melmed, S. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118388 · Cited by 78
Grossman, A. B., & BESSER, G. M. (1985) · BMJ · doi:10.1136/bmj.290.6463.182 · Cited by 77
Ezzat, S., Horváth, É., Kovács, K., et al. (1995) · Endocrine Pathology · doi:10.1007/bf02739875 · Cited by 68
Self-citationBennani-Baïti, I. M., Asa, S. L., Song, D., Iratni, R., Liebhaber, S. A., & Cooke, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10655 · Cited by 68
Self-citationBarker, H. M., Jones, T. A., Silva, E. F. D. C. E., Spurr, N. K., Sheer, D., & Cohen, P. T. W. (1990) · Genomics · doi:10.1016/0888-7543(90)90536-4 · Cited by 65
Mi-Ae, K. I. M., McClaskey, J. H., Bodenner, D., & Weintraub, B. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49472-6 · Cited by 63
Gonzalez, A. M., Logan, A., Ying, W., Lappi, D. A., Berry, M., & Baird, A. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156932 · Cited by 63
BRESSION, D., Benlot, C., Lagoguey, A., Garnier, P., Brandi, A., Gautron, J.-P., Legrand, J. C., & Peillon, F. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-572 · Cited by 63
Ray, D. W., Littlewood, A. C., Clark, A. J., Davis, J. R., & White, A. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117143 · Cited by 63
Pathogenesis of Pituitary Tumors
Molitch, M. E. (1987) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30462-6 · Cited by 63
Human Fetal Adenohypophysis: Morphologic and Functional Analysis in vitro
Asa, S. L., Kovács, K., & Singer, W. (2008) · Neuroendocrinology · doi:10.1159/000125775 · Cited by 60
Self-citationDisruption of the mouse oestrogen receptor gene: resulting phenotypes and experimental findings
Couse, J. F., Curtis, S. W., Washburn, T. F., Eddy, E. M., Schomberg, D. W., & Korach, K. S. (1995) · Biochemical Society Transactions · doi:10.1042/bst0230929 · Cited by 59
Yamada, M., Monden, T., Satoh, T., Satoh, N., Murakami, M., Iriuchijima, T., Kakegawa, T., & Mori, M. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2107 · Cited by 58
Nerve growth factor in the anterior pituitary: regulation of secretion
Patterson, J. C., & Childs, G. V. (1994) · Endocrinology · doi:10.1210/endo.135.4.7925134 · Cited by 56
Missale, C., Boroni, F., Sigala, S., Zanellato, A., Toso, R. D., Balsari, A., & Spano, P. (1994) · Endocrinology · doi:10.1210/endo.135.1.8013363 · Cited by 52
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Dopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983
“In view of these conflicting findings, an integrated approach that reconciles the two theories has emerged (408).”
BackgroundMicko, A. S. G., Wöhrer, A., Wolfsberger, S., & Knosp, E. (2015) · Journal of Neurosurgery · doi:10.3171/2014.12.jns141083 · Cited by 577
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
Zhang, X., Zhou, Y., Mehta, K. R., Danila, D. C., Scolavino, S., Johnson, S. R., & Klibanski, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030222 · Cited by 435
Metadata
- Authors
- Asa, S. L., & Ezzat, S.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1998-12-01
- Volume
- 19
- Issue
- 6
- Pages
- 798-827
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1963747253
- Cited by
- 388
- References
- 222
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.